152 related articles for article (PubMed ID: 7875170)
21. Staging lung carcinoma with a Tc-99m labeled monoclonal antibody.
Vansant JP; Johnson DH; O'Donnell DM; Stewart JR; Sonin AH; McCook BM; Powers TA; Salk DJ; Frist WH; Sandler MP
Clin Nucl Med; 1992 Jun; 17(6):431-8. PubMed ID: 1319860
[TBL] [Abstract][Full Text] [Related]
22. In-111 octreotide imaging in staging of small cell lung cancer.
Hochstenbag MM; Heidendal GA; Wouters EF; ten Velde GP
Clin Nucl Med; 1997 Dec; 22(12):811-6. PubMed ID: 9408640
[TBL] [Abstract][Full Text] [Related]
23. Uptake of In-111 pentetreotide by pleural plaques.
Lonneux M; Jamar F; Leners N; Pieters T; Pauwels S
Clin Nucl Med; 1998 May; 23(5):298-301. PubMed ID: 9596154
[TBL] [Abstract][Full Text] [Related]
24. 111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance.
Genestreti G; Bongiovanni A; Burgio MA; Burgio SL; Musto A; Rossi A; Monti M; Scarpi E; Ulivi P; Bravaccini S; Dubini A; Matteucci F; Gavelli G
Nucl Med Commun; 2015 Feb; 36(2):135-42. PubMed ID: 25321157
[TBL] [Abstract][Full Text] [Related]
25. [Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors].
Banzo J; Prats E; Razola P; García S; Alonso V; Velilla J; Freile E; Benito JL; García F; Ubieto MA; Tardín L; Abós MD
Rev Esp Med Nucl; 2005; 24(4):278-92. PubMed ID: 16122413
[No Abstract] [Full Text] [Related]
26. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
27. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
Vuillez JP; Moro D; Brichon PY; Rouvier E; Brambilla E; Barbet J; Peltier P; Meyer P; Sarrazin R; Brambilla C
J Nucl Med; 1997 Apr; 38(4):507-11. PubMed ID: 9098191
[TBL] [Abstract][Full Text] [Related]
28. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
29. Dynamic indium-111-pentetreotide scintigraphy in breast cancer.
Bajc M; Ingvar C; Palmer J
J Nucl Med; 1996 Apr; 37(4):622-6. PubMed ID: 8691252
[TBL] [Abstract][Full Text] [Related]
30. Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Corleto V; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
Int J Oncol; 2003 Dec; 23(6):1687-95. PubMed ID: 14612942
[TBL] [Abstract][Full Text] [Related]
31. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
32. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
Sarda L; Duet M; Zini JM; Berolatti B; Benelhadj S; Tobelem G; Mundler O
Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
[TBL] [Abstract][Full Text] [Related]
33. The role of somatostatin receptor scintigraphy (Octreoscan) during follow-up of patients after bronchial carcinoid resection. A prospective study.
Bini A; Grazia M; Stella F; Petrella F; Sellitri F; Fanti S; Monetti N; Bazzocchi R
J Cardiovasc Surg (Torino); 2005 Jun; 46(3):318-9. PubMed ID: 15956934
[No Abstract] [Full Text] [Related]
34. Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids.
Schillaci O; Scopinaro F; Danieli R; Angeletti S; Tavolaro R; Annibale B; Cannas P; Marignani M; Colella AC; Delle Fave G
Anticancer Res; 1997; 17(3B):1753-6. PubMed ID: 9179229
[TBL] [Abstract][Full Text] [Related]
35. Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphy.
Karyagar S; Mulazimoglu M; Karyagar SS; Halac M; Ozpacaci T
Cancer Imaging; 2008 Apr; 8(1):118-20. PubMed ID: 18442958
[TBL] [Abstract][Full Text] [Related]
36. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma].
Ukena D; Hellwig D; Palm I; Rentz K; Leutz M; Hellwig AP; Kirsch CM; Sybrecht GW
Pneumologie; 2000 Feb; 54(2):49-53. PubMed ID: 10731756
[TBL] [Abstract][Full Text] [Related]
37. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
Blum J; Handmaker H; Lister-James J; Rinne N
Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
[TBL] [Abstract][Full Text] [Related]
38. Computed tomographic evaluation of adrenal glands in patients with bronchogenic carcinoma.
Kaneko K; Hirata H; Nishitani H; Onitsuka H; Ono M; Matsuura K
Radiat Med; 1984; 2(4):231-3. PubMed ID: 6100396
[TBL] [Abstract][Full Text] [Related]
39. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
Lee JD; Kim DI; Lee JT; Chang JW; Park CY
J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
[TBL] [Abstract][Full Text] [Related]
40. [Computer tomography and staging of bronchogenic carcinoma. Prospective study].
Stolz AJ; Pipková R; Schützner J; Simonek J; Lischke R; Pafko P
Cas Lek Cesk; 2004; 143(11):752-4; discussion 754-5. PubMed ID: 15628570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
